Methyl 7-(bromomethyl)-9-oxo-9H-xanthene-1-carboxylate, 98%, 1g

Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate, 95.0%, 50mg

N-(1-benzylpyrrolidin-3-yl)-2,2,2-trifluoroacetamide, 98%, 5g

3-amino-1H-1,2,4-triazole-5-carboxylic acid, 95.0%, 100g

Homogeneizador según Potter-Elvehjem, 19, 1 ml 1 ud

(S)-di-tert-Butyl 2-(3-((S)-6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)ureido)pentanedioate, 95%, 5g

(2E)-3-(2,5-dimethoxyphenyl)-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 2g

1-Boc-3-(methoxy)azetidine, 95.0%, 25g

2-Bromo-4-formylthiazole, 98.0%, 10g

Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate, 97%, 1g

Tapón con cono estándar de plástico, 19/26, azul, 10 Unidad(es)

Ethyl 2-aminothiazole-4-carboxylate, 98.0%, 10g

Methyl 7-aminothieno[2,3-b]pyrazine-6-carboxylate, 90.0%, 250mg